Wednesday, March 21, 2018
Company News: Page (1) of 1 - 01/05/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Spruce Biosciences Receives EMA Orphan Drug Designation for SPR001 for the Treatment of Congenital Adrenal Hyperplasia
(January 05, 2018)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:USA,Medicine,Disease,Pregnancy,Surgery,Pregnancy,Science,Lifestyle,Medical,Adults,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines